Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes

Colloids and Surfaces B: Biointerfaces

Volumn 76, Issue 2, 2010, Pages 434-440

  Jung, Suk Hyun ^a,b   Kim, Sung Kyu ^a   Jung, Soon Hwa ^a   Kim, Eun Hye ^a   Cho, Sun Hang ^a   Jeong, Kyu Sung ^b   Seong, Hasoo ^a   Shin, Byung Cheol ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Albumin; Denaturation; Doxorubicin; Intracellular uptake; Liposome

Indexed keywords

ANTICANCER DRUG; BOVINE SERUM ALBUMINS; BSA MOLECULES; CATIONIC LIPOSOMES; CELLULAR UPTAKE; CIRCULATION TIME; DENATURED PROTEINS; DOXORUBICIN; DRUG CARRIER; DRUG DELIVERY CARRIER; ELECTROSTATIC INTERACTIONS; INTRACELLULAR UPTAKE; ISOELECTRIC POINT (PI); LOADING EFFICIENCY; MEAN PARTICLE DIAMETER; MODEL DRUGS; NANO SCALE; THERMAL TREATMENT;

BODY FLUIDS; CONFOCAL MICROSCOPY; DENATURATION; DRUG DELIVERY; FLOW CYTOMETRY; HEAT TREATMENT; LIPOSOMES; PHOSPHOLIPIDS;

PLASMA STABILITY;

BOVINE SERUM ALBUMIN; DOXORUBICIN; LIPOSOME;

ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG UPTAKE; ENCAPSULATION; FLOW CYTOMETRY; HEAT TREATMENT; INTRACELLULAR TRANSPORT; ISOELECTRIC POINT; NONHUMAN; PARTICLE SIZE; PH; PLASMA; PRIORITY JOURNAL; PROTEIN DENATURATION; SURFACE CHARGE;

ANIMALS; CATTLE; CELL LINE, TUMOR; DOXORUBICIN; DRUG STABILITY; LIPOSOMES; MICE; PARTICLE SIZE; PROTEIN DENATURATION; RATS; SERUM ALBUMIN, BOVINE; SURFACE PROPERTIES; TEMPERATURE;

BOVINAE;

EID: 75749128139     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2009.12.002     Document Type: Article

References (40)

1. Sharma A., and Sharma U.S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 154 (1997) 123-140
2. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005) 145-160
3. Bangham A.D., Standish M.M., and Watkins J.C. The first description of liposomes. J. Mol. Biol. 13 (1969) 238-252
4. Gabizon A., and Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Med. Sci. 85 (1988) 6949-6953
5. Liu D. Biological factors involved in blood clearance of liposomes by liver. Adv. Drug Deliv. Rev. 24 (1997) 201-213
6. Moghimi S.M., and Patel H.M. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system-the concept of tissue specificity. Adv. Drug Deliv. Rev. 32 (1998) 45-60
7. Torchilin V.P., and Trubetskoy V.S. Which polymers can make nanoparticlate drug carriers long-circulating?. Adv. Drug Deliv. Rev. 16 (1995) 141-155
8. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2000) 271-284
9. Shimada K., Matsuo S., Sadzuka Y., Miyagishima A., Nozawa Y., Hirota S., and Sonobe T. Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes. Int. J. Pharm. 203 (2000) 255-263
10. Sadzuka Y., Nakade A., Hirama R., Miyagishima A., Nozawa Y., Hirota S., and Sonobe T. Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int. J. Pharm. 238 (2002) 171-180
11. ® liposomes: from theory to product. Adv. Drug Deliv. Rev. 24 (1997) 165-177
12. Moghimi S.M., and Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issue in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42 (2003) 463-478
13. Romberg B., Metselaar J.M., Vringer T., Motonaga K., Bosch J.J.K., Oussoren C., Storm G., and Hennink W.E. Enzymatic degradation of liposome-grafted poly(hydroxyethyl L-glutamine). Bioconjug. Chem. 16 (2005) 767-774
14. Furumoto K., Yokoe J.I., Ogawara K., Amano S., Takaguchi M., Higaki K., Kai T., and Kimura T. Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition. Int. J. Pharm. 329 (2007) 110-116
15. Yokouchi Y., Tsunoda T., Imura T., Yamauchi H., Yokoyama S., Sakai H., and Abe M. Effect of adsorption of bovine serum albumin on liposomal membrane characteristics. Colloids Surf. B: Biointerfaces 20 (2001) 95-103
16. Leucuta S.E., Risca R., Daicoviciu D., and Porutiu D. Albumin microspheres as a drug delivery system for epirubicin: pharmaceutical, pharmacokinetic and biological aspects. Int. J. Pharm. 41 (1988) 213-217
17. Yokoe J., Sakuragi S., Yamamoto K., Teragaki T., Ogawara K., Higaki K., Katayama N., Kai T., Sato M., and Kimura T. Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats. Int. J. Pharm. 353 (2008) 28-34
18. Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int. J. Pharm. 289 (2005) 1-30
19. Nguyen V.T., Morange M., and Bensaude O. Protein denaturation during heat shock and related stress. J. Biol. Chem. 264 (1989) 10487-10492
20. Fields G.B., Alonso D.O.V., Stigter D., and Dill K.A. Theory for the aggregation of proteins and copolymers. J. Phys. Chem. 96 (1992) 3974-3981
21. Caflisch A., and Karplus M. Acid and thermal denaturation of barnase investigated by molecular dynamics simulations. J. Mol. Biol. 252 (1995) 672-708
22. Clarke J., and Itzhaki L.S. Hydrogen exchange and protein folding. Curr. Opin. Struct. Biol. 8 (1998) 112-118
23. Haran G., Cohen R., and Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochem. Biophys. Acta 1151 (1993) 201-215
24. Lasic D.D., Ceh B., Stuart M.C.A., Guo L., Frederik P.M., and Barenholz Y. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. Biochem. Biophys. Acta 1239 (1995) 145-156
25. Han H.D., Choi M.S., Hwang T., Song C.K., Seong H., Kim T.W., Choi H.S., and Shin B.C. Hyperthermia-induced antitumor activity of thermosensitive polymer modified temperature-sensitive liposomes. J. Pharm. Sci. 95 (2006) 1909-1917
26. Hwang T., Han H.D., Song C.K., Seong H., Kim J.H., Chen X., and Shin B.C. Anticancer drug-phospholipid conjugate for enhancement of intracellular drug delivery. Macromol. Symp. 249-250 (2007) 109-115
27. Xiong X.B., Huang Y., Lu W., Zhang X., Zhang H., Nagai T., and Zhang Q. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J. Control. Release 107 (2005) 262-275
28. Rader A.J., Hespenheide B.M., Kuhn L.A., and Thorpe M.F. Protein unfolding: rigidity lost. PNAS 99 (2002) 3540-3545
29. Koizumi M., Hirai H., Onai T., Inoue K., and Hirai M. Collapse of the hydration shell of a protein prior to thermal unfolding. J. Appl. Cryst. 40 (2007) s175-s178
30. Day R., Bennion B.J., Ham S., and Daggett V. Increasing temperature accelerates protein unfolding without changing the pathway of unfolding. J. Mol. Biol. 322 (2002) 189-203
31. Shimada K., Miyagishima A., Sadzuka Y., Nozawa Y., Mochizuki Y., Ohshima H., and Hirota S. Determination of thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes. J. Drug Target 3 (1995) 283-289
32. Dass C.R. Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature. Int. J. Pharm. 267 (2003) 1-12
33. Krasnici S., Werner A., Eichhorn M.E., Schmitt-Sody M., Pahernik S.A., Sauer B., Schulze B., Teifel M., Michaelis U., Naujoks K., and Dellian M. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int. J. Cancer 105 (2003) 561-567
34. Wu J., Lee A., Lu Y., and Lee R.J. Vascular targeting of doxorubicin using cationic liposomes. Int. J. Pharm. 337 (2007) 329-335
35. Chandaroy P., Sen A., Alexandridis P., and Hui S.W. Utilizing temperature-sensitive association of Pluronic F-127 with lipid bilayers to control liposome-cell adhesion. Biochem. Biophys. Acta 1559 (2002) 32-42
36. Haley B., and Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol. Oncol. 26 (2008) 57-64
37. Desai N., Trieu V., Damascelli B., and Soon-Shiong P. SPARC expression correlates with tumor response to albumin-bound paclitaxel in head and neck cancer patients. Trans. Oncol. 2 (2009) 59-64
38. Han H.D., Lee A., Song C.K., Hwang T., Seong H., Lee C.O., and Shin B.C. In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. Int. J. Pharm. 313 (2006) 181-188
39. Han H.D., Lee A., Hwang T., Song C.K., Seong H., Hyun J., and Shin B.C. Enhanced circulation time and tumor activity of doxorubicin by comblike polymer-incorporated liposomes. J. Control. Release 120 (2007) 161-168
40. Carmona-Ribeiro A.M., Ortis F., Schumacher R.I., and Armelin M.C.S. Interactions between cationic vesicles and cultured mammalian cells. Langmuir 13 (1997) 2215-2218